DiaGen AI / Longevity
Longevity Informed by Vigorous biomarker Evaluation — a first-mover continuous biochemical monitor for aging.
The opportunity
A minimally invasive, AI-powered wearable that reads consensus aging biomarkers from sweat and interstitial fluid in real time — letting consumers, clinicians, scientists and investors objectively judge whether any anti-aging intervention actually works.
Anti-aging interventions are multiplying with no reliable way to assess impact. Assessment today is episodic and invasive — labs, scans, visits — or unreliable self-report. Consensus markers such as IGF-1 and others are rarely run outside research labs, and existing wearables and lab platforms infer aging indirectly rather than measuring biochemistry continuously.
Sweat-based biological age index · 5 weighted pillars · 16+ proteins screened
Why DiaGen
Existing technologies cannot continuously detect proteins, cytokines and hormones in real time — current systems read small molecules on an episodic basis. DiaGen designs AI peptide binders that selectively recognise target biomarkers, enabling continuous, multiplexed molecular sensing.
Bespoke binders come from CYPRESS, using conditional sequence design across GFlowNets, protein LLMs and discrete diffusion. The team also carries wearable pedigree through Vitaliti and the Qualcomm Tricorder XPRIZE.
Unmet capability
Real-time detection of proteins, cytokines and hormones rather than episodic small-molecule reads.
Contribution
Selective recognition of target biomarkers for multiplexed molecular sensing.
Commercial shape
Biosensor plus AI analytics for early disease detection, licensed to diagnostics manufacturers.
Partner · Under NDA
A world-renowned domain expert in biosensing advises the programme. Scope of work is being defined post-NDA, covering peptide binders against specific ‘healthgevity’ biomarkers and joint development of AI-driven continuous monitoring devices.
Foundation publication: Biomarker Integration and Biosensor Technologies Enabling AI-Driven Insights into Biological Aging, Frontiers in Aging (2025). Medical advisor and board director: Sonny Kohli, MD FRCPC.
Read the research →For platform access, catalog partnering or co-development enquiries.
IR@diagen.ai